Show simple item record

dc.contributor.authorCipriani, Andrea
dc.date.accessioned2019-07-15T14:33:21Z
dc.date.available2019-07-15T14:33:21Z
dc.date.issued2019-06
dc.identifier.citationRuth H Jack, Chris Hollis, Carol Coupland, Richard Morriss, Roger David Knaggs, Andrea Cipriani, Samuele Cortese, Julia Hippisley-Cox. Trends in antidepressant prescriptions in children and young people in England, 1998–2017: protocol of a cohort study using linked primary care and secondary care datasets. Evidence-Based Mental Health Published Online First: 28 June 2019en
dc.identifier.issnISSN 1468-960X
dc.identifier.urihttps://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/272
dc.descriptionThis is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.en
dc.description.abstractIntroduction: Increasing numbers of children and young people (CYP) are receiving prescriptions for antidepressants. This is the protocol of a study aiming to describe the trends and variation in antidepressant prescriptions in CYP in England, and to examine the indications for the prescriptions recorded and whether there was contact with secondary care specialists on or around the time of the first antidepressant prescription. Methods and analysis: All eligible CYP aged between 5 and 17 years in 1998–2017 from the QResearch primary care database will be included. Incidence and prevalence rates of any antidepressant prescription in each year will be calculated. We will examine four different antidepressant classes: selective serotonin reuptake inhibitors, tricyclic and related antidepressants, serotonin and norepinephrine reuptake inhibitors and other antidepressants, as well as for individual drugs. Linked primary and secondary care data (hospital episode statistics) in the year before and up to 6 months after the first antidepressant prescription will be examined for CYP whose first antidepressant prescription was in 2006–2017. Whether there were records of indications and being seen by psychiatric or paediatric specialists will be identified. Trends over time and differences by region, deprivation and ethnicity will be examined using Poisson regression. Discussion: This large, population-based study will give an up-to-date picture of antidepressant prescribing in CYP and identify any variation. Understanding what indications are recorded when CYP are being prescribed antidepressants, and whether this was done in partnership with secondary care specialists, will provide evidence of whether appropriate guidelines are being followed.en
dc.description.sponsorshipSupported by the NIHRen
dc.description.urihttp://dx.doi.org/10.1136/ebmental-2019-300097
dc.language.isoenen
dc.subjectDepressive Disordersen
dc.subjectAntidepressant Drugsen
dc.subjectChildren and Adolescentsen
dc.titleTrends in antidepressant prescriptions in children and young people in England, 1998–2017: protocol of a cohort study using linked primary care and secondary care datasetsen
dc.typeArticleen


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record